Article
Synapses between corticotropin-releasing factor-containing axon terminals and dopaminergic neurons in the ventral tegmental area are predominantly glutamatergic.
Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland 21224, USA.
The Journal of Comparative Neurology (impact factor:
3.81).
03/2008;
506(4):616-26.
DOI:10.1002/cne.21576
pp.616-26
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems.
[show abstract] [hide abstract]
ABSTRACT: Allostasis, originally conceptualized to explain persistent morbidity of arousal and autonomic function, is defined as the process of achieving stability through physiological or behavioral change. Two types of biological processes have been proposed to describe the mechanisms underlying allostasis in drug addiction, a within-system adaptation and a between-system adaptation. In the within-system process, the drug elicits an opposing, neutralizing reaction within the same system in which the drug elicits its primary and unconditioned reinforcing actions, while in the between-system process, different neurobiological systems that the one initially activated by the drug are recruited. In this review, we will focus our interest on alterations in the dopaminergic and corticotropin releasing factor systems as within-system and between-system neuroadaptations respectively, that underlie the opponent process to drugs of abuse. We hypothesize that repeated compromised activity in the dopaminergic system and sustained activation of the CRF-CRF1R system with withdrawal episodes may lead to an allostatic load contributing significantly to the transition to drug addiction.Physiology & Behavior 11/2011; 106(1):58-64. · 2.87 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
corticotropin-releasing factor
CRF asymmetric synapses
CRF immunoreactivity present
CRF-immunolabeled axon terminals
CRF-immunoreactive axon terminals
electrophysiological studies
immunolabeling VTA sections
Interactions
majority likely
mediates stress responses
mesocorticolimbic DA system
possible interactions
producing DA
stress responses
stress-associated neuropeptide CRF
synapses coexpressed
synapses coexpressed glutamic acid decarboxylase
synaptic interactions
ventral tegmental area
vesicular glutamate transporter 2